Cargando…

HE4 level in ascites may assess the ovarian cancer chemotherapeutic effect

BACKGROUND: The clinical treatment of ovarian cancer with ascites is problematic. The main reasons for treatment failure are the susceptibility to intraperitoneal metastasis and chemotherapeutic drug resistance. The purpose and significance of this study is to evaluate which marker might evaluate tr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Duanyang, Kong, Dan, Li, Jing, Gao, Lei, Wu, Di, Liu, Yu, Yang, Weiwei, Zhang, Lei, Zhu, Jiang, Jin, Xiaoming
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2018
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6002981/ https://www.ncbi.nlm.nih.gov/pubmed/29903044 http://dx.doi.org/10.1186/s13048-018-0402-3

Ejemplares similares

Increased autophagy in EOC re-ascites cells can inhibit cell death and promote drug resistance
por: Liu, Yu, et al.
Publicado: (2018)

The impact of inflammatory cells in malignant ascites on small intestinal ICCs’ morphology and function
por: Li, Jing, et al.
Publicado: (2015)

Clinical Significance of Screening Differential Metabolites in Ovarian Cancer Tissue and Ascites by LC/MS
por: Liu, Miao, et al.
Publicado: (2021)

Oncolytic adenovirus inhibits malignant ascites of advanced ovarian cancer by reprogramming the ascitic immune microenvironment
por: Shi, Gang, et al.
Publicado: (2021)

Preclinical Efficacy and Safety Assessment of Artemisinin-Chemotherapeutic Agent Conjugates for Ovarian Cancer
por: Li, Xiaoguang, et al.
Publicado: (2016)

The Effects of Chemotherapeutics on the Ovarian Cancer Microenvironment
por: Eckert, Mark A., et al.
Publicado: (2021)

Ascites-derived CDCP1+ extracellular vesicles subcluster as a novel biomarker and therapeutic target for ovarian cancer
por: Kong, Lingnan, et al.
Publicado: (2023)

Elevated Levels of Lewis Y and Integrin α(5)β(1) Correlate with Chemotherapeutic Drug Resistance in Epithelial Ovarian Carcinoma
por: Hu, Zhenhua, et al.
Publicado: (2012)

Mediation Analysis Reveals Potential Biological Mechanism of Ascites Influencing Recurrence in Patients with Epithelial Ovarian Cancer
por: Yang, Chunyan, et al.
Publicado: (2020)

Ascitic complement system in ovarian cancer
por: Bjørge, L, et al.
Publicado: (2005)

The bright side of ascites in ovarian cancer
por: Cohen, Marie, et al.
Publicado: (2014)

Ascites Volumes and the Ovarian Cancer Microenvironment
por: Penet, Marie-France, et al.
Publicado: (2018)

Mirk kinase inhibition targets ovarian cancer ascites
por: Deng, Xiaobing, et al.
Publicado: (2014)

Ascites Index – an attempt to objectify the assessment of ascites
por: Szkodziak, Piotr, et al.
Publicado: (2018)

Effect of Gallic acid in potentiating chemotherapeutic effect of Paclitaxel in HeLa cervical cancer cells
por: Aborehab, Nora M., et al.
Publicado: (2019)

Identification and Functional Validation of Differentially Expressed microRNAs in Ascites-Derived Ovarian Cancer Cells Compared with Primary Tumour Tissue
por: Jiang, Yahui, et al.
Publicado: (2021)

Route to high-energy density polymeric nitrogen t-N via He−N compounds
por: Li, Yinwei, et al.
Publicado: (2018)

Assessment of cells in the ascitic fluid of women with ovarian hyperstimulation syndrome: the clinical implications for subsequent ovarian malignancy
por: Hatzipetros, Ioannis, et al.
Publicado: (2013)

Disaggregation and invasion of ovarian carcinoma ascites spheroids
por: Burleson, Kathryn M, et al.
Publicado: (2006)

Deciphering the ovarian cancer ascites fluid peptidome
por: Bery, Anand, et al.
Publicado: (2014)

Chlamydia Peritonitis and Ascites Mimicking Ovarian Cancer
por: Gojayev, Anar, et al.
Publicado: (2016)

Immune Tumor Microenvironment in Ovarian Cancer Ascites
por: Almeida-Nunes, Diana Luísa, et al.
Publicado: (2022)

Clinical and biological effects of tumor associated lymphocytes in the presence or absence of chemotherapy for malignant ascites in ovarian cancer patients
por: Zhang, Weiwei, et al.
Publicado: (2018)

Clinical and biological effects of tumor-associated lymphocytes in the presence or absence of chemotherapy for malignant ascites in ovarian cancer patients
por: Zhang, Weiwei, et al.
Publicado: (2017)

Coughing May Lead to Spontaneous Chylothorax and Chylous Ascites
por: Adas, Gokhan, et al.
Publicado: (2007)

Prognostic significance of IL-6 and IL-8 ascites levels in ovarian cancer patients
por: Lane, Denis, et al.
Publicado: (2011)

Falsely Elevated CA 15-3 Levels in Ovarian Sarcoidosis with Peritoneal Involvement and Ascites
por: Tsiodras, Sotirios, et al.
Publicado: (2018)

In vitro sensitivity of human ovarian tumours to chemotherapeutic agents.
por: Wilson, A. P., et al.
Publicado: (1981)

Tumor cell-fibroblast heterotypic aggregates in malignant ascites of patients with ovarian cancer
por: Han, Qing, et al.
Publicado: (2019)

A Novel Model of Solitary Hepatic Tumor in Rats Using Ascites Hepatoma AH13: Suitability for Chemotherapeutic Studies
por: Tamura, Yoshihiro, et al.
Publicado: (1990)

Eps15 homology domain 1 promotes the evolution of papillary thyroid cancer by regulating endocytotic recycling of epidermal growth factor receptor
por: Liu, Yu, et al.
Publicado: (2018)

The untapped potential of ascites in ovarian cancer research and treatment
por: Ford, Caroline Elizabeth, et al.
Publicado: (2020)

Association between hyperpolarization-activated channel in interstitial cells of Cajal and gastrointestinal dysmotility induced by malignant ascites
por: Guo, Tieyun, et al.
Publicado: (2017)

Modeling the effect of ascites-induced compression on ovarian cancer multicellular aggregates
por: Klymenko, Yuliya, et al.
Publicado: (2018)

Metformin improves the sensitivity of ovarian cancer cells to chemotherapeutic agents
por: Yang, Chen, et al.
Publicado: (2019)

Sitagliptin Modulates the Response of Ovarian Cancer Cells to Chemotherapeutic Agents
por: Kosowska, Agnieszka, et al.
Publicado: (2020)

Association of preoperative IL-6 levels with overt HE in patients with cirrhosis after TIPS
por: Li, JinYu, et al.
Publicado: (2023)

The efficacy of chemotherapeutic drug combinations may be predicted by concordance of gene response to the single agents
por: Gravett, Andrew M., et al.
Publicado: (2020)

Massive hemorrhagic ascites: A rare presentation of eosinophilic gastroenteritis
por: Shi, Lei, et al.
Publicado: (2018)

Prediction of chemotherapeutic resistance in serous ovarian cancer with low-density custom microarray
por: Zhu, Hong-Lan, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_kla6rlh55qqsuvn70fts5hv6t4